CAS: 827318-97-8 - Danusertib

Fórmula: C₂₆H₃₀N₆O₃

InChI: InChI=1/C26H30N6O3/c1-30-12-14-31(15-13-30)20-10-8-19(9-11-20)25(33)27-24-21-16-32(17-22(21)28-29-24)26(34)23(35-2)18-6-4-3-5-7-18/h3-11,23H,12-17H2,1-2H3,(H2,27,28,29,33)/t23-/m1/s1

Sinónimos:

• N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
• N-{5-[(2R)-2-methoxy-2-phenylacetyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl}-4-(4-methylpiperazin-1-yl)benzamide

N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide

CAS: 827318-97-8

• Fórmula: C₂₆H₃₀N₆O₃
• Cor e Forma: Solid
• Peso molecular: 474.5548

Danusertib

CAS: 827318-97-8

Danusertib (PHA-739358) is a small-molecule 3-aminopyrazole derivative with potential antineoplastic activity. Danusertib binds to and …

• Fórmula: C₂₆H₃₀N₆O₃
• Pureza: 98.44%
• Cor e Forma: White Powder
• Peso molecular: 474.55

Danusertib

CAS: 827318-97-8

Danusertib

CAS: 827318-97-8

Inhibitor of aurora kinases

• Fórmula: C₂₆H₃₀N₆O₃
• Pureza: Min. 95%
• Cor e Forma: White Powder
• Peso molecular: 474.57 g/mol

Danusertib

CAS: 827318-97-8

Applications An Aurora kinase inhibitor, used to treat patients with chromic myeloid leukemia. It is …

• Fórmula: C₂₆H₃₀N₆O₃
• Cor e Forma: Neat
• Peso molecular: 474.55